Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
about
Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.Both the N-terminal fragment and the protein-protein interaction domain (PDZ domain) are required for the pro-apoptotic activity of presenilin-associated protein PSAPA compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF functionsAnalysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways.Sporadic amyotrophic lateral sclerosis: a hypothesis of persistent (non-lytic) enteroviral infection.Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.Mitochondrial pathobiology in ALS.7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis.Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALSNeurotrophins and neurodegeneration.Molecular and cellular pathways of neurodegeneration in motor neurone diseaseAlterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis.Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosisBiology of mitochondria in neurodegenerative diseases.Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical application.Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.TDP-43 and ubiquitinated cytoplasmic aggregates in sporadic ALS are low frequency and widely distributed in the lower motor neuron columns independent of disease spread.Mitochondria in neuroplasticity and neurological disorders.The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.Noninvasive detection of brainstem and spinal cord axonal degeneration in an amyotrophic lateral sclerosis mouse modelAmyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever.Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis.Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice.Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis.Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic AcidCopy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach.Characterization of the caspase cascade in a cell culture model of SOD1-related familial amyotrophic lateral sclerosis: expression, activation and therapeutic effects of inhibition.Expression of ErbB4 in the apoptotic neurons of Alzheimer's disease brain.In vitro reactive nitrating species toxicity in dissociated spinal motor neurons from NFL (-/-) and hNFL (+/+) transgenic mice.Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration.Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients.The role of Melatonin receptor MTNR1A in the action of Melatonin on bovine granulosa cells.Bcl-2 family and the central nervous system: from rheostat to real complex.Synaptic Failure: Focus in an Integrative View of ALS.
P2860
Q27687333-07AF1322-9854-4DF2-B41B-E3C1C1417C6CQ28269581-48377178-217E-4E51-87A7-54E8670347BEQ30627872-E7B20282-E8FC-4496-A89A-77948245BC32Q33185412-43479A59-D172-46CF-8C99-2F9CB1974D92Q33220088-94A8B0CF-AF59-4AD8-8D98-C5B492970067Q33361835-8DEF8FBE-4A8B-4275-896F-408BE259AD43Q34038775-594AADA3-659F-483D-AF5A-D10C4EAB70B5Q34410523-4CFC9013-6C18-4509-BDB9-46869AF3311BQ34502221-C94D495A-C8E6-415C-AA8D-E9A787EF2FF9Q34640994-5E7FFF51-5A13-41FF-956F-096B99DF20D1Q34973926-E869F73A-73EA-464F-A341-74439CF83BBDQ35145450-202C2E75-83AA-4F9A-988A-021C6C5180D1Q35489359-A9263CC0-FB2E-4570-AEAB-4894038F74D8Q35791339-C24E0B82-2416-410A-85F1-3B422C76ED7EQ35809317-5684FA00-ACAC-4C7C-93D9-C306FC60E6CCQ36095965-4A573EEA-6160-48C6-92B2-DF3FCD7A87ABQ36488715-84BA62EC-2692-4754-9501-A4423465CA82Q36565588-A2179C0D-5D35-448D-8D7A-606738B56541Q36565671-F683BCEB-C13A-4EF1-8F3F-ECC51F98D3A4Q36861432-F923F3AE-35DC-4133-98AA-0D6A906CC421Q37167760-1DCCFACB-79CA-4005-933E-412D7B385B35Q37216404-6DDBD114-1898-491C-87D5-155F2A9F2833Q37466115-E4852CEB-1748-415E-BFFD-BF6ADCE1A68FQ37529730-0FB33F7D-1593-466C-ACD2-01E3829E05EFQ37590212-462DC6EA-7A93-417A-9186-60BDBA6437FBQ37980249-973DC596-98BE-40C6-A564-8BCA1A1699C5Q38296647-8F5C81F0-EA43-4493-BAB4-1B339FC6C26FQ38518708-8465BC4A-4D50-412D-B68A-BF75AFEB5085Q38725129-3EC768AF-6FF9-4F97-9408-321C8A731F3CQ39102149-A94F52BF-0677-4488-925B-9DE1E93D9DF8Q40376012-1066EB78-55DA-40B7-AF55-E33D8CC9A027Q42077740-6B710C48-1CE4-4156-AAD8-1D1E5E9D4DC1Q44594674-C16C397F-8811-4992-A7A2-E9DF7A65B131Q46724078-B4D37B96-993A-4F8D-8082-104CD31808BCQ46863053-9EF4F22C-08CF-4CB6-8359-68174D5A4C29Q46891717-F6B907D5-6642-4AAE-96DD-E1A32FBFA759Q48103298-FEB94346-612B-45A3-B2DF-4B238312CB1CQ48245500-01B248AD-9335-49E5-8200-3A08962D133CQ53620970-5685DDAF-2B60-4C27-8F0E-6D620E1EAA64Q55233896-A2947C2E-6F86-4C8E-A0DE-50564DC1C3F8
P2860
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@ast
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@en
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@nl
type
label
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@ast
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@en
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@nl
prefLabel
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@ast
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@en
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.
@nl
P2860
P1476
Apoptosis in amyotrophic lateral sclerosis: a review of the evidence
@en
P2093
S Sathasivam
P2860
P304
P356
10.1046/J.0305-1846.2001.00332.X
P577
2001-08-01T00:00:00Z